Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi NajafZadeh

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Diabetes, Obesity & Metabolism|November 3, 2021
Effectiveness and safety of empagliflozin in routine care patients: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) studyElisabetta Patorno, Ajinkya Pawar, Deborah J Wexler, et al.
Diabetes Care|June 25, 2024
Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 DiabetesPhyo Than Htoo, Mehdi NajafZadeh, Helen Tesfaye, et al.
Circulation|April 9, 2019
Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical CareElisabetta Patorno, Ajinkya Pawar, Jessica M Franklin, et al.
Journal of Comparative Effectiveness Research|August 30, 2018
Characteristics of early sacubitril/valsartan patients and considerations for studies in electronic health record dataJoshua J Gagne, Theodore Tsacogianis, Sara Bruce Wirta, et al.
JAMA Network Open|October 20, 2022
Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient CharacteristicsPhyo T Htoo, Helen Tesfaye, Sebastian Schneeweiss, et al.
Lancet (London, England)|November 13, 2010
Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trialRichard T Lester, Paul Ritvo, Edward J Mills, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Cost-effectiveness of endovascular versus open surgery for chronic limb-threatening ischemiaZafar Zafari, Mehdi Najafzadeh, Mufaddal Mahesri, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Diabetes, Obesity & Metabolism|November 3, 2021
Effectiveness and safety of empagliflozin in routine care patients: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) studyElisabetta Patorno, Ajinkya Pawar, Deborah J Wexler, et al.
Diabetes Care|June 25, 2024
Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 DiabetesPhyo Than Htoo, Mehdi NajafZadeh, Helen Tesfaye, et al.
Circulation|April 9, 2019
Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical CareElisabetta Patorno, Ajinkya Pawar, Jessica M Franklin, et al.
Journal of Comparative Effectiveness Research|August 30, 2018
Characteristics of early sacubitril/valsartan patients and considerations for studies in electronic health record dataJoshua J Gagne, Theodore Tsacogianis, Sara Bruce Wirta, et al.
JAMA Network Open|October 20, 2022
Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient CharacteristicsPhyo T Htoo, Helen Tesfaye, Sebastian Schneeweiss, et al.
Lancet (London, England)|November 13, 2010
Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trialRichard T Lester, Paul Ritvo, Edward J Mills, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Cost-effectiveness of endovascular versus open surgery for chronic limb-threatening ischemiaZafar Zafari, Mehdi Najafzadeh, Mufaddal Mahesri, et al.
Pageof 6